Uppsala-Umeå Comprehensive Cancer Consortium (U-CAN)
U-CAN is a longitudinal collection of data and blood and tissue samples from cancer patients in Sweden. Initially, recruitment targeted patients with brain tumours, colorectal cancers, haematological malignancies, and prostate cancers and was later extended to include gynaecological cancers, breast cancers, neuroendocrine tumours, and lung cancers. Patients recruited into U-CAN are adults diagnosed with any of the selected cancer types living in either the Uppsala or Västerbotten counties, or that have been referred to the two university hospitals for diagnosis, treatment, and/or follow-up from surrounding counties. Over 12,000 cancer patients had been included in U-CAN as of the end of 2016.
Study design
Cohort, Cohort - clinical, Biobank
Number of participants at first data collection
12,265 (participants as of 2016)
Recruitment is ongoing
Age at first data collection
> 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2010
Primary Institutions
KTH Royal Institute of Technology (Kungliga Tekniska högskolan)
Stockholm University (Stockholms universitet)
Umeå University (Umeå Universitet)
Uppsala University (Uppsala universitet, UU)
Profile paper DOI
Funders
Government of the Kingdom of Sweden (Konungariket Sveriges regering)
Uppsala Region Government (Region Uppsala)
Uppsala University
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
